🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

TEC

MOLECULAR TARGET

tec protein tyrosine kinase

UniProt: P42680NCBI Gene: 700630 compounds

TEC (tec protein tyrosine kinase) is targeted by 30 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TEC

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1osimertinib5.03152
2ibrutinib4.86128
3foretinib4.3476
4tozasertib4.3375
5bosutinib4.0858
6canertinib3.5333
7tae 6843.4330
8mln 80543.3327
9acalabrutinib3.2224
10rociletinib3.1823
11jnj 77066213.0921
12at 92833.0921
13lestaurtinib3.0420
14spebrutinib3.0420
15pf 037583093.0019
16danusertib2.9418
17r 4062.8316
18ritlecitinib2.7715
19apitolisib2.7114
20zanubrutinib2.5612
21mk 51082.4811
22poziotinib2.4811
23evobrutinib2.4811
24azd 77622.309
25asp 30262.087
26tirabrutinib1.956
27pf 038147351.795
28tolebrutinib1.795
29Dasatinib0.691
30bdb pf 06651600 us11111242 example 5 us9617258 example 50.691

About TEC as a Drug Target

TEC (tec protein tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 30 compounds with documented TEC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TEC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.